You are here

Cobimetinib

Key FDA Decisions and Trial Results Expected in October

24/7 Wall St

Tue, 10/4/16 - 10:07 am

clinical trials

Celldex Therapeutics

Cerulean Pharma

Anthera Pharmaceuticals

Key FDA Decisions and Trial Results Coming in the Next 2 Months

24/7 Wall St

Wed, 09/14/16 - 11:53 pm

clinical trials

Array Biopharma

Mast Therapeutics

Threshold Pharmaceuticals

Cerulean Pharma

Vertex Pharmaceuticals

Key FDA Decisions and Trial Results Expected in October

24/7 Wall St

Thu, 09/8/16 - 09:50 am

clinical trials

Celldex Therapeutics

Cerulean Pharma

Anthera Pharmaceuticals

Genentech, Exelixis score another PhIII success for cobimetinib

Fierce Biotech

Tue, 10/6/15 - 09:59 am

Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!"

Motley Fool

Sun, 07/5/15 - 11:03 am

FDA taps the brakes on Genentech's cobimetinib review

Fierce Biotech

Wed, 07/1/15 - 04:08 pm

Roche and Exelixis roll toward FDA approval with a melanoma cocktail

Fierce Biotech

Thu, 02/19/15 - 10:41 am

Does This Drug Offer Exelixis Inc. Investors Hope for the Future?

Motley Fool

Fri, 01/2/15 - 08:25 am

Roche submits NDA for skin cancer med

Seeking Alpha

Mon, 12/15/14 - 11:09 am

Should Roche Buy Exelixis?

Motley Fool

Thu, 07/17/14 - 08:54 am

Roche, Exelixis Skin Cancer Drug Delays Tumor Progression

TheStreet.com

Mon, 07/14/14 - 10:32 am

Exelixis Announces Presentation of Updated Phase 1b Data for Cobimetinib (GDC-0973/XL518) in Combination with Vemurafenib at ECC 2013

Yahoo/BusinessWire

Sat, 09/28/13 - 11:58 am

metastatic melanoma